Tenaya Therapeutics Inc.

NASDAQ: TNYA · Real-Time Price · USD
1.09
0.14 (15.11%)
At close: Aug 15, 2025, 1:08 PM

Tenaya Therapeutics Income Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Revenue
n/a n/a n/a n/a
Cost of Revenue
n/a 8.69M 8.71M 4.03M
Gross Profit
n/a -8.69M -8.71M -4.03M
Operating Income
-115.95M -131.19M -125.62M -72.81M
Interest Income
4.74M 7.06M 1.95M 108K
Pretax Income
-111.13M -124.08M -123.67M -72.72M
Net Income
-111.13M -124.08M -123.66M -69.65M
Selling & General & Admin
29.21M 33.16M 31.08M 18.41M
Research & Development
86.74M 98.04M 94.54M 54.39M
Other Expenses
n/a n/a 2K -23K
Operating Expenses
115.95M 131.19M 125.62M 72.81M
Interest Expense
n/a n/a n/a n/a
Selling & Marketing Expenses
n/a n/a n/a n/a
Cost & Expenses
n/a 131.19M 125.62M 72.81M
Income Tax Expense
n/a n/a -1.96K -3.07M
Shares Outstanding (Basic)
84.82M 73.79M 44.82M 41.29M
Shares Outstanding (Diluted)
84.82M 73.79M 44.82M 41.29M
EPS (Basic)
-1.31 -1.68 -2.76 -1.69
EPS (Diluted)
-1.31 -1.68 -2.76 -1.69
EBITDA
-102.66M -122.51M -114.95M -68.7M
EBIT
-111.13M -131.19M -123.67M -72.72M
Depreciation & Amortization
8.47M 8.69M 8.71M 4.03M